Matthew Dodds
Matthew Dodds
boston dominate johnson market seems
It seems like (Johnson & Johnson and Boston Scientific) are going to dominate the market at least through '06.
board company damaged destroying value
They are destroying the value of their company for a damaged asset. What is their board thinking?
board boston components extra issues
Even with the new components of the Boston offer, we don't think Guidant's board will get comfortable enough with the aforementioned antitrust issues and the extra $1.